MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Apathy and Risk of Parkinson’s Disease: A Population-Based Cohort Study

A. Otaiku (London, United Kingdom)

Meeting: 2025 International Congress

Keywords: Apathy, Disease-modifying strategies, Parkinson’s

Category: Parkinson's Disease: Epidemiology, Phenomenology, Clinical Assessment, Rating Scales

Objective: This study investigated the association between apathy and the risk of incident Parkinson’s disease (PD) in community-dwelling adults.

Background: Apathy is a core neuropsychiatric symptom of PD. Whether apathy may be a prodromal symptom of PD is unknown.

Method: This prospective cohort study used data from 4,527 men (mean age = 77 years [range: 69-97]) from the Osteoporotic Fractures in Men Study (MrOS) and 19,082 men and women (mean age = 58 years [range: 18-96]; 65.3% female) from PPMI Online (PPMI). All participants were free from PD at baseline. Apathy at baseline was measured using the 3-item subscale of the Geriatric Depression Scale [GDS-3A]. Incident PD at follow-up was based on doctor-diagnosis. Multivariable logistic regression was used to estimate odds ratios (OR) for incident PD according to baseline apathy symptoms (none, mild, moderate, severe).

Results: In MrOS, 106 (2.4%) participants developed PD over 11.1-years of follow-up. In PPMI, 398 (2.1%) participants developed PD over 3.4-years of follow-up. After adjusting for demographic characteristics, compared with those who were free from apathy at baseline, participants with severe apathy had a 3.2-fold risk of developing PD in MrOS (OR: 3.23; 95% CI 1.64–6.37) and a 6.4-fold risk of developing PD in PPMI (OR: 6.36; 95% CI 4.61–8.78). Moreover, there was a dose–response relationship between increasing apathy severity and increasing PD risk (MrOS: P <0.001 for trend; PPMI: P <0.001 for trend). Associations between apathy and PD remained significant after adjusting for a wide range of possible confounders, and after excluding PD cases that developed within 2 years after baseline.

Conclusion: In two community-based cohorts, apathy was associated with an increased risk of developing PD, suggesting it may represent an important prodromal symptom of PD. These findings may help to identify individuals at risk of PD and could facilitate early prevention strategies.

To cite this abstract in AMA style:

A. Otaiku. Apathy and Risk of Parkinson’s Disease: A Population-Based Cohort Study [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/apathy-and-risk-of-parkinsons-disease-a-population-based-cohort-study/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/apathy-and-risk-of-parkinsons-disease-a-population-based-cohort-study/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley